Popular Articles
Revitol Cellulite Cream

Growth Factor Identified As Possible Cancer Drug Target By UNC Scientists
To grow and spread, tumors need new blood vessels, a process called angiogenesis. One growth factor that causes angiogenesis has been identified - vascular endothelial growth factor or VEGF - and drugs to inhibit VEGF are already in use. But not all tumors respond to the therapy initially or over the long term. Thus new growth factors need to be identified to aid in developing the next generation of angiogenesis inhibitors. Don't forget to buy zoloft online no prescription.

Today's Selection Of Opinions And Editorials
The Patients Doctors Don"t Know The New York Times

generic viagra online


News of the day
Human Term Placenta A New Abundant Of Hematopoietic Cells
Investigators at Children"s Hospital Oakland Research Institute, Oakland, California found a way to obtain large numbers of hematopoietic stem cell from human term placenta. The results, which appear in the July 2009 issue of Experimental Biology and Medicine, describe detailed report on quantification, characterization, engraftment capacity, and most importantly, practical way to obtain hematopoietic stem cells from placenta in numbers that are several-fold higher than could be obtained from cord blood.
Endocrinology

Alabama Dept. of Public Health Proposes Civil Penalty Against Company For Not Properly Maintaining Security, Accountability Of Radioactive s

The Alabama Department of Public Health has proposed a $650 civil penalty against BFGoodrich Tire Manufacturing of Tuscaloosa for a violation of the Rules of the State Board of Health. The department identified the violation when BFGoodrich reported in May that two devices containing radioactive s were missing from the Tuscaloosa plant site. BFGoodrich reported that these devices were last accounted for in October 2008 and were discovered missing on April 22, 2009. The devices have not been located or recovered and may have left the plant site when the production line on which they were attached was dismantled and removed as scrap. Each contained small amounts of the isotope Americium 241. The violation involved the failure of BFGoodrich to properly maintain security and accountability of radioactive s. Such devices are used in fixed gauges that measure the thickness of rubber product during production. "We expect all companies that hold Alabama Radioactive Material licenses to maintain control and accountability of all nuclear material by adhering to the rules," said Kirksey E. Whatley, director of the Office of Radiation Control. "This violation is a concern because someone could have been exposed to radiation if the devices were found and mishandled. There is also the possibility that the devices could be melted as scrap and thus cause radioactive contamination at the steel mill and in recycled steel produced by the mill." Following the discovery of the missing devices, BFGoodrich took immediate corrective actions to properly account for all remaining radioactive devices on site, to retrain employees in the importance of maintaining security and accountability of devices, and to institute revised safety procedures for s of radiation. BFGoodrich Tire Manufacturing has until July 31 to pay or contest the proposed civil penalty. If the proposed civil penalty is contested, and subsequently imposed by the Alabama Department of Public Health, the company may request a hearing. For additional information on the regulation of devices containing radioactive material, please call the Office of Radiation Control, Alabama Department of Public Health, at 1-800-582-1866 or visit http://www.adph.org/radiation. Alabama Department of Public Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):